Snowball logo
logo
4521

Kaken Pharmaceutical Co Ltd

4521 • TSE
¥3,785.00-¥45.00  (1.17%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20222023202420252026TTM
Revenue
Total revenue
76,03472,98472,04494,03576,87188,158
COGS
34,45833,42833,50535,77337,63137,067
Gross Profit
41,57639,55638,53958,26239,24051,091
Operating Expenses & Income
Operating Income
17,0647,9989,51321,036(899)9,991
Total Operating Expenses
24,50831,55329,02637,22640,13941,100
R&D Expenses
8,42015,78912,54318,72520,58519,802
Selling General & Admin Expenses
15,83315,47631---
Earnings from Continuing Operations
Interest Expense
(17)(17)(17)(28)(45)(49)
Interest Income
349395877275-
Income Tax Expense
4,3361,3771,7705,4901682,834
Net Income
Net Income
9,5495,4408,02513,9452,14410,312
Supplemental
EBIT
13,9036,8349,81619,4662,35812,841
EBITDA
16,3849,40212,56922,0205,68316,529
In millions of JPY, except % and values per 1 share